All lobbying filings
AVIVA STRATEGIES (FKA MGB CONSULTING)
AVIVA STRATEGIES (FKA MGB CONSULTING) filed a Q1 termination report for ULTRAGENYX PHARMACEUTICAL on April 20, 2026.
Lobbying for ULTRAGENYX PHARMACEUTICAL · Biopharma company
Filing · LD-2 quarterly report
Q1 termination
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 20, 2026
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
California
Representation ended
Jan 5, 2026
The registrant reported terminating its work for this client.
Lobbying activity
1
n/a termination report